FDA inspection
Biofrontera Discovery GmbH: FDA inspection ending May 7, 2026
FDA inspection 1316680 · Voluntary Action Indicated (VAI) · Leverkusen
Key facts
| Inspection ID | 1316680 |
|---|---|
| Firm | Biofrontera Discovery GmbH |
| FEI number | 3042623717 |
| Address | Hemmelrather Weg 201 |
| City | Leverkusen |
| Country | Germany |
| Fiscal year | 2026 |
| Inspection end date | May 7, 2026 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data